Back to Agenda
EDC Insights: Before, During, and After
Session Chair(s)
Maryanne Nicosia, MS
Executive Director, Clinical Data Management
Neurocrine Biosciences, Inc, United States
Electronic Data Capture: The Importance and Impact of Selecting the Optimum EDC Platform for Your Clinical Program
Learning Objective : Discuss the importance of ensuring optimum efficiency gains from selecting an EDC system; Define a list of questions (quantitative framework) that can be used to assist in EDC system selection; Evaluate ROI from choosing the appropriate EDC system; Explain the quantitative and qualitative costs of switching EDC platforms; Identify the most common EDC challenges and cost-effective solutions; Discuss trends in conducting postmarketing trials using EDC, focusing on changing needs/priorities.
Speaker(s)
Love the One You're With: The High Costs of Switching EDC Platforms and How to Get the Most Out of Your Current One
Kent Mahoney, MBA
Soltex Consulting LLP, United States
Managing Director
Considerations for Using EDC in Late Phase Research
Patrick Chassaigne, MS
Medidata Solutions Worldwide, United States
Director, CRO Partnerships, Americas
Electronic Data Capture: The Importance and Impact of Selecting the Optimum EDC Platform for Your Clinical Program
Toby Odenheim, MBA
Parker Institute For Cancer Immunotherapy, United States
Director, Technology & Governance
Have an account?